Medical device manufacturing is where Indian healthcare policy is pushing hardest — 70–80% of devices are still imported, and PLI schemes, medical-device parks and CDSCO's regularised licensing regime are all built to change that. Lenders have followed: device makers today access manufacturing finance on terms that reflect a priority sector, not a niche.
The funding stack mirrors pharma manufacturing with a devices accent: term loans for factory setup and expansion; machinery finance for injection moulding, extrusion, sterilisation (ETO/gamma), tooling and cleanroom assembly lines at 75–90% of cost; automation capex; working capital sized on component inventories and hospital/distributor receivables; and — for the many exporters in this segment — concessional pre-shipment and post-shipment export credit lines.
Regulatory posture drives appraisal quality: CDSCO manufacturing license (MD-5/MD-9 as applicable), ISO 13485 certification and CE/US-FDA registrations where exports are involved. Udyam-registered units layer CGTMSE cover for collateral-light structures. We build files that put these credentials up front and place them with lenders active in MedTech.
What device makers fund
Production machinery
Injection moulding, extrusion, tube lines, assembly and tooling at 75–90% funding.
Sterilisation & cleanrooms
ETO/gamma sterilisation capacity and ISO-class cleanroom builds.
Automation
Robotic assembly and inspection systems that lift throughput and compliance.
Factory expansion
New blocks and units — including in dedicated medical-device parks.
Export finance
Pre-shipment (packing credit) and post-shipment lines at concessional rates.
Certification capex
ISO 13485, CE-marking and US-FDA readiness costs folded into project finance.
Interest rates & terms (2026, indicative)
| Lender type | Interest rate | Typical LTV / funding |
|---|---|---|
| Public sector banks | 9.50% – 11.50% p.a. | Term & machinery, keenest pricing |
| Private banks | 10.00% – 12.50% p.a. | Composite limits incl. export credit |
| NBFC machinery programs | 11.00% – 13.00% p.a. | Fast machinery finance to 90% |
Rates are indicative market ranges for mid-2026 and vary by lender policy, credit profile and security. Final pricing rests with the sanctioning bank/NBFC.
Eligibility (typical)
- CDSCO manufacturing license appropriate to device class
- ISO 13485 (or committed roadmap) — near-mandatory for serious files
- 3+ years' vintage for expansion; promoter pedigree for greenfield
- Orders/contracts or export LCs supporting projections
- Margin 20–35% by structure; CGTMSE reduces collateral need
- PCB consents and factory compliances current
Documents required
- CDSCO license (MD-5/MD-9) & device registrations
- ISO 13485 / CE / FDA certificates as held
- Machinery quotations & project cost sheet
- 3 years' audited financials, ITRs, GST returns
- 12 months' banking; order book / export LCs
- Factory compliance set: PCB, fire, factory license
Device Mfg Loan EMI Calculator
Indicative only — final rate and eligibility are decided by the lender based on your profile and security.
How CreditCares gets you sanctioned faster
Profile & lender match
We map your financials and security to the lenders — from our 80+ bank & NBFC panel — most likely to approve on the best terms.
Bank-ready file
Financials, projections, property/KYC papers structured exactly the way credit teams want to see them.
Negotiation & follow-up
We place the file with multiple lenders, negotiate rate, LTV and fees, and keep approvals moving.
Sanction & disbursal
Terms finalised, sanction issued, funds disbursed — tracked end to end by one team.
Frequently asked questions
What export credit can a device exporter access?
Pre-shipment packing credit funds production against confirmed orders/LCs, and post-shipment credit bridges the receivable until payment — both at concessional export-credit pricing, with interest-equalisation benefits where the scheme applies to your product lines. These sit alongside, not instead of, your regular limits.
Are disposables (syringes, gloves, catheters) makers funded like device makers?
Yes — high-volume disposables are the segment's bread and butter. Appraisal centres on line capacity, utilisation and buyer contracts (hospital chains, government tenders, export buyers). Machinery-heavy expansions fund at 75–90% of equipment cost.
Does setting up inside a medical-device park help financing?
It helps meaningfully: plug-and-play infrastructure cuts project cost and time, park land-lease structures are mortgage-friendly with authority NOCs, and lenders are familiar with park economics. Some states add capital subsidies for park units — we fold those into the model.
Can R&D and certification costs be financed?
Within a project structure, yes — ISO 13485 implementation, CE technical files, testing and validation are legitimate project cost lines. Pure standalone R&D lending is thinner; for early-stage innovation, the healthcare-startup funding route is often the better fit.
We import components — how does that affect working capital?
Import-heavy BOMs need limits that cover LC/buyer's-credit for components plus longer inventory pipelines. We structure composite limits (funded + non-funded LC/BG) so component imports, production and receivables are all covered in one sanctioned facility.
Related loan products
Pharmaceutical Manufacturing Loan
View →Pharma Machinery Loan
View →MSME Loan for Pharma
View →Pharma & Healthcare Loans — hub
View →Get the right lender, not just any lender
Share a few details and a CreditCares expert will map your eligibility across 80+ banks & NBFCs — free, confidential, no obligation. Since 2012 · ₹2,000 Cr+ facilitated · 4.9★ on Google.
Get my free eligibility check Call +91 98300 38870Disclaimer: CreditCares is a private loan consultancy / DSA — not a bank, NBFC or government body. Interest rates, LTV and eligibility parameters shown are indicative market ranges for 2026 and change with lender policy. Loan approval, pricing and terms rest solely with the sanctioning bank/NBFC. Tax notes are general summaries — consult a Chartered Accountant before claiming deductions.